Biopact

PATENTED TECHNOLOGY THAT MAKES FIGHTING DISEASE SIMPLER, FASTER AND CHEAPER.
Analytics
Raised to Date: $876,778
Aggregate Commitments $
Equifund CFP
02/26/2020
02/12/2021
$20,000
$1,070,000
$465
Equity - Common
RegCF
Seed
$30,000,000
Weekly Commitments $
Active
01/20/2021
21
4,384%
82%
$2,665
764
Healthcare & Pharmaceuticals
Biotech
B2B
High
High
Biopact Cellular Transport, with a valuation of $30 million, is raising funds on Equifund Crowd Funding Platform. The company has a unique patented intracellular delivery technology that transports gene-editing technologies to cells effectively, safely, and affordably. The delivery mechanism of Biopact Cellular Transport will help reduce the cost and increase the effectiveness of therapies like CRISPR, TALEN, and CAR-T. Biopact Cellular Transport was founded by Kurt Swogger and is led by Randy Kinsel as the President. The current crowdfunding round of the company has a minimum target of $20,000 and a maximum target of $1,070,000. Biopact Cellular Transport’s MGMR technology is protected by 77 patents worldwide and has the potential to revolutionize cellular medicines.
Summary Profit and Loss Statement
Most Recent Year | Prior Year | |
---|---|---|
Revenue |
$0 |
$0 |
COGS |
$0 |
$0 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$-59 |
$0 |
Summary Balance Sheet
Most Recent Year | Prior Year | |
---|---|---|
Cash |
$3,041 |
$0 |
Accounts Receivable |
$0 |
$0 |
Total Assets |
$3,041 |
$0 |
Short-Term Debt |
$0 |
$0 |
Long-Term Debt |
$0 |
$0 |
Total Liabilities |
$0 |
$0 |
Analyst Report
Ratings Platform - Beta Trial
Our new ratings and analytics platform is currently in Beta. To gain access to the Beta platform features, upgrade to a Pro paid account and accept the Beta terms on any page.
For a limited time, use coupon code "TRYMERLIN20" for a free 20 day trial of Kingscrowd Pro and Merlin Beta. Your paid subscription will activate at the end of 20 days. Cancel anytime.Other Deals

Millennial Fertility Co. on NetCapital
The Millennial Fertility Co. team has been selected as a “Deal to Watch” by KingsCrowd. This distinction is…

Neurotez Inc. on NetCapital
Neurotez has been selected as a “Deal To Watch” by KingsCrowd. This distinction is reserved for deals selected…

SanMelix Laboratories on StartEngine
The SanMelix Labs team has been selected as a “Top Deal” by KingsCrowd. This distinction is reserved for…